Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Association of Orthostatic Hypotension Timing with Clinical Events in Adults with Diabetes and Hypertension: Results from the ACCORD Trial.

Juraschek SP, Lipsitz LA, Beach JL, Mukamal KJ.

Am J Hypertens. 2019 Jan 31. doi: 10.1093/ajh/hpz015. [Epub ahead of print]

PMID:
30715100
2.

Effects of sodium intake on postural lightheadedness: Results from the DASH-sodium trial.

Peng AW, Appel LJ, Mueller NT, Tang O, Miller ER 3rd, Juraschek SP.

J Clin Hypertens (Greenwich). 2019 Jan 28. doi: 10.1111/jch.13487. [Epub ahead of print]

3.

Blood Pressure Assessment in Adults in Clinical Practice and Clinic-Based Research: JACC Scientific Expert Panel.

Muntner P, Einhorn PT, Cushman WC, Whelton PK, Bello NA, Drawz PE, Green BB, Jones DW, Juraschek SP, Margolis KL, Miller ER 3rd, Navar AM, Ostchega Y, Rakotz MK, Rosner B, Schwartz JE, Shimbo D, Stergiou GS, Townsend RR, Williamson JD, Wright JT Jr, Appel LJ; 2017 National Heart, Lung, and Blood Institute Working Group.

J Am Coll Cardiol. 2019 Jan 29;73(3):317-335. doi: 10.1016/j.jacc.2018.10.069. Review.

PMID:
30678763
4.

Comparison of automated clinical and research blood pressure measurements: Implications for clinical practice and trial design.

Tang O, Juraschek SP, Appel LJ, Cooper LA, Charleston J, Boonyasai RT, Carson KA, Yeh HC, Miller ER 3rd.

J Clin Hypertens (Greenwich). 2018 Dec;20(12):1676-1682. doi: 10.1111/jch.13412. Epub 2018 Nov 7.

5.

Hypertension Treatment Effects on Orthostatic Hypotension and Its Relationship With Cardiovascular Disease.

Juraschek SP, Appel LJ, Miller ER 3rd, Mukamal KJ, Lipsitz LA.

Hypertension. 2018 Oct;72(4):986-993. doi: 10.1161/HYPERTENSIONAHA.118.11337.

PMID:
30354704
6.

Rationale and design of the Study To Understand Fall Reduction and Vitamin D in You (STURDY): A randomized clinical trial of Vitamin D supplement doses for the prevention of falls in older adults.

Michos ED, Mitchell CM, Miller ER 3rd, Sternberg AL, Juraschek SP, Schrack JA, Szanton SL, Walston JD, Kalyani RR, Plante TB, Christenson RH, Shade D, Tonascia J, Roth DL, Appel LJ; STURDY Collaborative Research Group.

Contemp Clin Trials. 2018 Oct;73:111-122. doi: 10.1016/j.cct.2018.08.004. Epub 2018 Aug 20.

PMID:
30138718
7.

Comparison of Frequency of Atherosclerotic Cardiovascular and Safety Events With Systolic Blood Pressure <120mm Hg Versus 135-139mm Hg in a Systolic Blood Pressure Intervention Trial Primary Prevention Subgroup.

Plante TB, Juraschek SP, Miller ER 3rd, Appel LJ, Cushman M, Littenberg B.

Am J Cardiol. 2018 Oct 1;122(7):1185-1190. doi: 10.1016/j.amjcard.2018.06.041. Epub 2018 Jul 4.

PMID:
30115425
8.

Design Features of Randomized Clinical Trials of Vitamin D and Falls: A Systematic Review.

Tang O, Juraschek SP, Appel LJ.

Nutrients. 2018 Jul 26;10(8). pii: E964. doi: 10.3390/nu10080964. Review.

9.

Association of orthostatic hypotension with incident dementia, stroke, and cognitive decline.

Rawlings AM, Juraschek SP, Heiss G, Hughes T, Meyer ML, Selvin E, Sharrett AR, Windham BG, Gottesman RF.

Neurology. 2018 Aug 21;91(8):e759-e768. doi: 10.1212/WNL.0000000000006027. Epub 2018 Jul 25.

PMID:
30045960
10.

Orthostatic Hypotension and Risk of Clinical and Subclinical Cardiovascular Disease in Middle-Aged Adults.

Juraschek SP, Daya N, Appel LJ, Miller ER 3rd, McEvoy JW, Matsushita K, Ballantyne CM, Selvin E.

J Am Heart Assoc. 2018 May 7;7(10). pii: e008884. doi: 10.1161/JAHA.118.008884.

11.

Reply: The Role of Salt Reduction in the Management of Hypertension.

Juraschek SP, Miller ER 3rd, Appel LJ.

J Am Coll Cardiol. 2018 Apr 10;71(14):1598-1599. doi: 10.1016/j.jacc.2018.02.012. No abstract available.

PMID:
29622171
12.

Late life socioeconomic status and hypertension in an aging cohort: the Atherosclerosis Risk in Communities Study.

McDoom MM, Palta P, Vart P, Juraschek SP, Kucharska-Newton A, Diez Roux AV, Coresh J.

J Hypertens. 2018 Jun;36(6):1382-1390. doi: 10.1097/HJH.0000000000001696.

PMID:
29621068
13.

Orthostatic Hypotension and Symptoms in the AASK Trial.

Juraschek SP, Miller ER 3rd, Appel LJ.

Am J Hypertens. 2018 May 7;31(6):665-671. doi: 10.1093/ajh/hpy010.

PMID:
29370333
14.

Use of online recruitment strategies in a randomized trial of cancer survivors.

Juraschek SP, Plante TB, Charleston J, Miller ER, Yeh HC, Appel LJ, Jerome GJ, Gayles D, Durkin N, White K, Dalcin A, Hermosilla M.

Clin Trials. 2018 Apr;15(2):130-138. doi: 10.1177/1740774517745829. Epub 2018 Jan 24.

PMID:
29361843
15.

Predictors of Insulin Initiation in Patients with Type 2 Diabetes: An Analysis of the Look AHEAD Randomized Trial.

Pilla SJ, Yeh HC, Juraschek SP, Clark JM, Maruthur NM.

J Gen Intern Med. 2018 Jun;33(6):839-846. doi: 10.1007/s11606-017-4282-9. Epub 2018 Jan 19.

PMID:
29352421
16.

Effects of a Dietary Approach to Stop Hypertension (DASH) Diet Intervention on Serum Uric Acid in African Americans With Hypertension.

Juraschek SP, White K, Tang O, Yeh HC, Cooper LA, Miller ER 3rd.

Arthritis Care Res (Hoboken). 2018 Oct;70(10):1509-1516. doi: 10.1002/acr.23515. Epub 2018 Aug 21.

PMID:
29342506
17.

Effects of Sodium Reduction and the DASH Diet in Relation to Baseline Blood Pressure.

Juraschek SP, Miller ER 3rd, Weaver CM, Appel LJ.

J Am Coll Cardiol. 2017 Dec 12;70(23):2841-2848. doi: 10.1016/j.jacc.2017.10.011. Epub 2017 Nov 12.

18.

Chronic kidney disease: Intensive blood pressure reduction lowers mortality in CKD.

Juraschek SP, Appel LJ.

Nat Rev Nephrol. 2018 Jan;14(1):5-6. doi: 10.1038/nrneph.2017.154. Epub 2017 Nov 7. No abstract available.

19.

Time Course of Change in Blood Pressure From Sodium Reduction and the DASH Diet.

Juraschek SP, Woodward M, Sacks FM, Carey VJ, Miller ER 3rd, Appel LJ.

Hypertension. 2017 Nov;70(5):923-929. doi: 10.1161/HYPERTENSIONAHA.117.10017.

20.

Metoprolol Increases Uric Acid and Risk of Gout in African Americans With Chronic Kidney Disease Attributed to Hypertension.

Juraschek SP, Appel LJ, Miller ER 3rd.

Am J Hypertens. 2017 Sep 1;30(9):871-875. doi: 10.1093/ajh/hpx113.

21.

Association of History of Dizziness and Long-term Adverse Outcomes With Early vs Later Orthostatic Hypotension Assessment Times in Middle-aged Adults.

Juraschek SP, Daya N, Rawlings AM, Appel LJ, Miller ER 3rd, Windham BG, Griswold ME, Heiss G, Selvin E.

JAMA Intern Med. 2017 Sep 1;177(9):1316-1323. doi: 10.1001/jamainternmed.2017.2937.

22.

Relation of Exercise Capacity to Risk of Development of Diabetes in Patients on Statin Therapy (the Henry Ford Exercise Testing Project).

Shaya GE, Juraschek SP, Feldman DI, Brawner CA, Ehrman JK, Keteyian SJ, Al-Mallah MH, Blaha MJ.

Am J Cardiol. 2017 Sep 1;120(5):769-773. doi: 10.1016/j.amjcard.2017.05.048. Epub 2017 Jun 15.

PMID:
28716336
23.

Effects of dietary carbohydrate on 1,5-anhydroglucitol in a population without diabetes: results from the OmniCarb trial.

Juraschek SP, Miller ER 3rd, Appel LJ, Christenson RH, Sacks FM, Selvin E.

Diabet Med. 2017 Oct;34(10):1407-1413. doi: 10.1111/dme.13391. Epub 2017 Jul 9.

24.

DASH diet and change in serum uric acid over time.

Tang O, Miller ER 3rd, Gelber AC, Choi HK, Appel LJ, Juraschek SP.

Clin Rheumatol. 2017 Jun;36(6):1413-1417. doi: 10.1007/s10067-017-3613-x. Epub 2017 Mar 31.

25.

Pilot study of the effect of cholecalciferol supplementation on hepcidin in children with chronic kidney disease: Results of the D-fense Trial.

Atkinson MA, Juraschek SP, Bertenthal MS, Detrick B, Furth SL, Miller ER 3rd.

Pediatr Nephrol. 2017 May;32(5):859-868. doi: 10.1007/s00467-016-3563-6. Epub 2016 Dec 24.

26.

Opposing effects of sodium intake on uric acid and blood pressure and their causal implication.

Juraschek SP, Choi HK, Tang O, Appel LJ, Miller ER 3rd.

J Am Soc Hypertens. 2016 Dec;10(12):939-946.e2. doi: 10.1016/j.jash.2016.10.012. Epub 2016 Nov 11.

27.

Effect of type and amount of dietary carbohydrate on biomarkers of glucose homeostasis and C reactive protein in overweight or obese adults: results from the OmniCarb trial.

Juraschek SP, Miller ER 3rd, Selvin E, Carey VJ, Appel LJ, Christenson RH, Sacks FM.

BMJ Open Diabetes Res Care. 2016 Nov 14;4(1):e000276. eCollection 2016.

28.

Phosphorus Additives and Albuminuria in Early Stages of CKD: A Randomized Controlled Trial.

Chang AR, Miller ER 3rd, Anderson CA, Juraschek SP, Moser M, White K, Henry B, Krekel C, Oh S, Charleston J, Appel LJ.

Am J Kidney Dis. 2017 Feb;69(2):200-209. doi: 10.1053/j.ajkd.2016.08.029. Epub 2016 Nov 16.

29.

Orthostatic Hypotension in Middle-Age and Risk of Falls.

Juraschek SP, Daya N, Appel LJ, Miller ER 3rd, Windham BG, Pompeii L, Griswold ME, Kucharska-Newton A, Selvin E.

Am J Hypertens. 2017 Feb;30(2):188-195. doi: 10.1093/ajh/hpw108. Epub 2016 Sep 16.

30.

Effects of the Dietary Approaches to Stop Hypertension (DASH) Diet and Sodium Intake on Serum Uric Acid.

Juraschek SP, Gelber AC, Choi HK, Appel LJ, Miller ER 3rd.

Arthritis Rheumatol. 2016 Dec;68(12):3002-3009. doi: 10.1002/art.39813.

31.

Effect of glycemic index and carbohydrate intake on kidney function in healthy adults.

Juraschek SP, Chang AR, Appel LJ, Anderson CA, Crews DC, Thomas L, Charleston J, Miller ER 3rd.

BMC Nephrol. 2016 Jul 8;17(1):70. doi: 10.1186/s12882-016-0288-5.

32.

The association of clinical indication for exercise stress testing with all-cause mortality: the FIT Project.

Kim J, Al-Mallah M, Juraschek SP, Brawner C, Keteyian SJ, Nasir K, Dardari ZA, Blumenthal RS, Blaha MJ.

Arch Med Sci. 2016 Apr 1;12(2):303-9. doi: 10.5114/aoms.2016.59255. Epub 2016 Apr 12.

33.

Sex Differences in Cardiorespiratory Fitness and All-Cause Mortality: The Henry Ford ExercIse Testing (FIT) Project.

Al-Mallah MH, Juraschek SP, Whelton S, Dardari ZA, Ehrman JK, Michos ED, Blumenthal RS, Nasir K, Qureshi WT, Brawner CA, Keteyian SJ, Blaha MJ.

Mayo Clin Proc. 2016 Jun;91(6):755-62. doi: 10.1016/j.mayocp.2016.04.002. Epub 2016 May 6.

34.

Response to Letter Regarding Article, "Cardiorespiratory Fitness and Risk of Incident Atrial Fibrillation: Results From the Henry Ford Exercise Testing (FIT) Project".

Qureshi WT, Alirhayim Z, Blaha MJ, Juraschek SP, Keteyian SJ, Brawner CA, Al-Mallah MH.

Circulation. 2015 Dec 22;132(25):e395. doi: 10.1161/CIRCULATIONAHA.115.018758. No abstract available.

PMID:
26700015
35.

Effects of Lowering Glycemic Index of Dietary Carbohydrate on Plasma Uric Acid Levels: The OmniCarb Randomized Clinical Trial.

Juraschek SP, McAdams-Demarco M, Gelber AC, Sacks FM, Appel LJ, White KJ, Miller ER 3rd.

Arthritis Rheumatol. 2016 May;68(5):1281-9. doi: 10.1002/art.39527.

36.

The Gamma Gap and All-Cause Mortality.

Juraschek SP, Moliterno AR, Checkley W, Miller ER 3rd.

PLoS One. 2015 Dec 2;10(12):e0143494. doi: 10.1371/journal.pone.0143494. eCollection 2015.

37.

Response to Comment on Juraschek et al. Cardiorespiratory Fitness and Incident Diabetes: The FIT (Henry Ford ExercIse Testing) Project. Diabetes Care 2015;38:1075-1081.

Juraschek SP, Blaha MJ, Al-Mallah MH.

Diabetes Care. 2015 Nov;38(11):e194-5. doi: 10.2337/dci15-0007. No abstract available.

PMID:
26494817
38.

Stage A Heart Failure Is Not Adequately Recognized in US Adults: Analysis of the National Health and Nutrition Examination Surveys, 2007-2010.

Kovell LC, Juraschek SP, Russell SD.

PLoS One. 2015 Jul 14;10(7):e0132228. doi: 10.1371/journal.pone.0132228. eCollection 2015.

39.

Cardiorespiratory Fitness and Risk of Incident Atrial Fibrillation: Results From the Henry Ford Exercise Testing (FIT) Project.

Qureshi WT, Alirhayim Z, Blaha MJ, Juraschek SP, Keteyian SJ, Brawner CA, Al-Mallah MH.

Circulation. 2015 May 26;131(21):1827-34. doi: 10.1161/CIRCULATIONAHA.114.014833. Epub 2015 Apr 22.

PMID:
25904645
40.

Cardiorespiratory fitness and incident diabetes: the FIT (Henry Ford ExercIse Testing) project.

Juraschek SP, Blaha MJ, Blumenthal RS, Brawner C, Qureshi W, Keteyian SJ, Schairer J, Ehrman JK, Al-Mallah MH.

Diabetes Care. 2015 Jun;38(6):1075-81. doi: 10.2337/dc14-2714. Epub 2015 Mar 12.

PMID:
25765356
41.

Physical fitness and hypertension in a population at risk for cardiovascular disease: the Henry Ford ExercIse Testing (FIT) Project.

Juraschek SP, Blaha MJ, Whelton SP, Blumenthal R, Jones SR, Keteyian SJ, Schairer J, Brawner CA, Al-Mallah MH.

J Am Heart Assoc. 2014 Dec;3(6):e001268. doi: 10.1161/JAHA.114.001268.

42.

Comparative associations of diabetes risk factors with five measures of hyperglycemia.

Poon AK, Juraschek SP, Ballantyne CM, Steffes MW, Selvin E.

BMJ Open Diabetes Res Care. 2014 Apr 8;2(1):e000002. doi: 10.1136/bmjdrc-2013-000002. eCollection 2014.

43.

Relation of resting heart rate to risk for all-cause mortality by gender after considering exercise capacity (the Henry Ford exercise testing project).

Aladin AI, Whelton SP, Al-Mallah MH, Blaha MJ, Keteyian SJ, Juraschek SP, Rubin J, Brawner CA, Michos ED.

Am J Cardiol. 2014 Dec 1;114(11):1701-6. doi: 10.1016/j.amjcard.2014.08.042. Epub 2014 Sep 16.

PMID:
25439450
44.

Gout, urate-lowering therapy, and uric acid levels among adults in the United States.

Juraschek SP, Kovell LC, Miller ER 3rd, Gelber AC.

Arthritis Care Res (Hoboken). 2015 Apr;67(4):588-92. doi: 10.1002/acr.22469.

45.

Plasma lactate and incident hypertension in the atherosclerosis risk in communities study.

Juraschek SP, Bower JK, Selvin E, Subash Shantha GP, Hoogeveen RC, Ballantyne CM, Young JH.

Am J Hypertens. 2015 Feb;28(2):216-24. doi: 10.1093/ajh/hpu117. Epub 2014 Jul 3.

46.

Two authors reply.

Juraschek SP, Selvin E.

Am J Epidemiol. 2014 May 1;179(9):1148-9. doi: 10.1093/aje/kwu057. Epub 2014 Mar 26. No abstract available.

47.

Serum uric acid and the risk of mortality during 23 years follow-up in the Scottish Heart Health Extended Cohort Study.

Juraschek SP, Tunstall-Pedoe H, Woodward M.

Atherosclerosis. 2014 Apr;233(2):623-9. doi: 10.1016/j.atherosclerosis.2014.01.026. Epub 2014 Jan 30.

48.

Temporal relationship between uric acid concentration and risk of diabetes in a community-based study population.

Juraschek SP, McAdams-Demarco M, Miller ER, Gelber AC, Maynard JW, Pankow JS, Young H, Coresh J, Selvin E.

Am J Epidemiol. 2014 Mar 15;179(6):684-91. doi: 10.1093/aje/kwt320. Epub 2014 Jan 12.

49.

Plasma lactate and diabetes risk in 8045 participants of the atherosclerosis risk in communities study.

Juraschek SP, Selvin E, Miller ER, Brancati FL, Young JH.

Ann Epidemiol. 2013 Dec;23(12):791-796.e4. doi: 10.1016/j.annepidem.2013.09.005. Epub 2013 Oct 5.

50.

Acute gout after renal transplantation with notable hypouricemia.

Juraschek SP, Kurano T, Rosen A, Gelber AC.

Am J Med. 2013 Oct;126(10):e5-6. doi: 10.1016/j.amjmed.2013.04.008. Epub 2013 Jul 24. No abstract available.

PMID:
23891284

Supplemental Content

Loading ...
Support Center